News

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) released interim data from a Phase 1 trial evaluating soquelitinib in patients with moderate to severe atopic dermatitis. The trial will enroll 64 patients with moderate to severe atopic dermatitis who previously failed one prior topical or systemic therapy. These doses were selected based on the company’s prior experience evaluating soquelitinib in T-cell lymphoma patients. The company is reporting complete results from Cohort 1 of the trial, which inc

Tender rejection rate rises as holidays approach The tender rejection rate has risen steadily since early October despite tender volume declining. That implies that capacity is leaving the market, which […] The post Freight market shows additional signs of recovery appeared first on FreightWaves.

On Wednesday, Merck & Co Inc (NYSE:MRK) and Hansoh Pharma, a Chinese biopharmaceutical company, entered into an exclusive global license agreement for HS-10535, an investigational preclinical oral small molecule GLP-1 receptor agonist. Under the agreement, Hansoh Pharma has granted Merck an exclusive global license to develop, manufacture, and commercialize HS-10535. Hansoh Pharma will receive an upfront payment of $112 million and is eligible to receive up to $1.9 billion in milestone payments

(Bloomberg) -- A whopping 1130% rally in the shares of a Brazilian waste management company is drawing the attention of the country’s stock exchange operator. Most Read from BloombergNYPD Car Chases Are Becoming More Frequent — and More DangerousB3 SA, the company behind Brazil’s stock exchange, requested clarification on “atypical fluctuations” in the shares of Ambipar Participacoes e Empreendimentos SA that took place between Dec. 11 and 13, according to a note. On those days, the stock surged

A new report identifies data content management as the primary driver of growth in the pharmaceuticals market.

U.S. equities gained at midday ahead of what's expected to be the announcement of another interest-rate cut from the Federal Reserve.

The Dow Jones Industrial Average is riding its longest stretch of consecutive daily losses since 1974. Healthcare controversy and the peculiar way the index is calculated lie behind the slump.